eConsult Medical: what changed
eConsult Medical
Largest movements
- Receivables within one year -€90,498
down €90,498 (-29.4%), from €307,374 to €216,876
of which Trade receivables: -€159,131
- Cash +€21,300
up €21,300 (+62.7%), from €33,991 to €55,290
mainly Receivables within one year (+€90,498) and Net result for the year (+€8,181)
- Trade debts -€65,271
down €65,271 (-67.8%), from €96,286 to €31,015
of which Suppliers: -€76,286
- Reserves +€8,181
up €8,181 (+5.1%), from €161,796 to €169,977
of which Distributable reserves: +€8,181
- Tax, wage and social debts -€8,101
down €8,101 (-22.4%), from €36,229 to €28,128
- Current portion of long-term debt -€6,618
down €6,618 (-12.5%), from €52,857 to €46,240
- Taxes -€21,722
down €21,722 (-93.6%), from €23,202 to €1,480
- Gross operating margin +€3,550
up €3,550 (+4.4%), from €80,411 to €83,961
- Financial income +€3,002
up €3,002 (+202%), from €1,483 to €4,485
- Other operating charges -€2,627
down €2,627 (-30.0%), from €8,759 to €6,132
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €405,892 | €337,557 | -€68,335 | -16.8% |
| Fixed assets | 21/28 | €5,767 | €5,594 | -€173 | -3.0% |
| Tangible fixed assets | 22/27 | €1,567 | €1,394 | -€173 | -11.0% |
| Plant, machinery and equipment | 23 | €1,567 | €1,394 | -€173 | -11.0% |
| Financial fixed assets | 28 | €4,200 | €4,200 | = | 0.0% |
| Current assets | 29/58 | €400,125 | €331,963 | -€68,163 | -17.0% |
| Amounts receivable after more than one year | 29 | €46,400 | €46,400 | = | 0.0% |
| Other amounts receivable | 291 | €46,400 | €46,400 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €307,374 | €216,876 | -€90,498 | -29.4% |
| Trade receivables | 40 | €278,004 | €118,873 | -€159,131 | -57.2% |
| Other amounts receivable | 41 | €29,370 | €98,003 | +€68,633 | +234% |
| Cash at bank and in hand | 54/58 | €33,991 | €55,290 | +€21,300 | +62.7% |
| Deferred charges and accrued income | 490/1 | €12,361 | €13,396 | +€1,036 | +8.4% |
| Total equity and liabilities | 10/49 | €405,892 | €337,557 | -€68,335 | -16.8% |
| Equity | 10/15 | €211,383 | €219,564 | +€8,181 | +3.9% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €161,796 | €169,977 | +€8,181 | +5.1% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €159,936 | €168,117 | +€8,181 | +5.1% |
| Profit (loss) carried forward | 14 | €43,387 | €43,387 | = | 0.0% |
| Amounts payable | 17/49 | €194,509 | €117,993 | -€76,516 | -39.3% |
| Amounts payable within one year | 42/48 | €194,509 | €117,993 | -€76,516 | -39.3% |
| Current portion of amounts payable after more than one year | 42 | €52,857 | €46,240 | -€6,618 | -12.5% |
| Financial debts | 43 | €9,137 | €12,610 | +€3,474 | +38.0% |
| Credit institutions | 430/8 | €9,137 | €12,610 | +€3,474 | +38.0% |
| Trade debts | 44 | €96,286 | €31,015 | -€65,271 | -67.8% |
| Suppliers | 440/4 | €76,286 | - | -€76,286 | |
| Bills of exchange payable | 441 | €20,000 | €31,015 | +€11,015 | +55.1% |
| Taxes, remuneration and social security | 45 | €36,229 | €28,128 | -€8,101 | -22.4% |
| Taxes | 450/3 | €36,229 | €28,128 | -€8,101 | -22.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €230 | €173 | -€58 | -25.0% |
| Other operating charges | 640/8 | €8,759 | €6,132 | -€2,627 | -30.0% |
| Non-recurring operating charges | 66A | - | €58,857 | +€58,857 | |
| Gross operating margin | 9900 | €80,411 | €83,961 | +€3,550 | +4.4% |
| Operating profit (loss) | 9901 | €71,421 | €18,800 | -€52,621 | -73.7% |
| Financial income | 75/76B | €1,483 | €4,485 | +€3,002 | +202% |
| Recurring financial income | 75 | €1,483 | €4,485 | +€3,002 | +202% |
| Financial charges | 65/66B | €13,059 | €13,624 | +€565 | +4.3% |
| Recurring financial charges | 65 | €13,059 | €13,624 | +€565 | +4.3% |
| Profit (loss) for the period before taxes | 9903 | €59,845 | €9,661 | -€50,184 | -83.9% |
| Income taxes | 67/77 | €23,202 | €1,480 | -€21,722 | -93.6% |
| Profit (loss) for the period | 9904 | €36,643 | €8,181 | -€28,462 | -77.7% |
| Profit (loss) for the period to be appropriated | 9905 | €36,643 | €8,181 | -€28,462 | -77.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.